Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2005-12-07

Original market date: See footnote 1

1990-12-31

Product name:

SUPRAX

DIN:

02195992 Electronic product monograph is not available

Company:

AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

08:12.06.12 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01DD08 CEFIXIME

Active ingredient group (AIG) number:See footnote5

0122105001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
CEFIXIME 100 MG / 5 ML
Version 4.0.3

"Page details"

Date modified: